Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
60 participants
INTERVENTIONAL
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Comparison Study of Patient Controlled Epidural Analgesia (PCEA) With and Without Basal Infusion Using Ropivacaine 0,15% and Fentanyl μg/ml for Pain Relief in Labor, Assessment of Efficacy and Maternal Satisfaction.
NCT02084589
Spinal Fentanyl or Epidural Analgesia in the Early First Phase of Induced Labor
NCT04645823
Effect of Epidural Opioid Administered in the First A Period on the Progress of Labour
NCT03344042
Role of the Single-shot Spinal Analgesia to Control Labour Pain
NCT02800694
Effect of Epidural Analgesia on the Length of Labor and Delivery and Fetal Outcomes
NCT02396563
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fentanyl
20 microgram per hour
Fentanyl
Normal saline
0.4 ml per hour
Normal saline
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Fentanyl
Normal saline
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* nulliparous
* normal singleton uncomplicated pregnancies of more than 38 weeks
* cephalic presentation of the fetus
* anticipated vaginal delivery
* active stage of labour
* cervical dilatation between 3-5 cm
* regular uterine contractions
* normal cardiotocographic recordings.
Exclusion Criteria
* BMI≥40 kg m-2
* opioid allergy
* prior administration of opioids or other analgesics
20 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Athens
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Staikou Chryssoula
Assistant Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Chryssoula Staikou, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Athens
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Aretaieio Hospital, University of Athens
Athens, Attica, Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M79
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.